Research and Markets Announces the Addition of Monoclonal Antibody Based Products - Global Strategic Business Report
Complete the form below to unlock access to ALL audio articles.
Research and Markets has announced the addition of Monoclonal Antibody Based Products - Global Strategic Business Report to their offering.
This report analyzes the worldwide markets for Monoclonal Antibody Based Products in Millions of US$.
The major product segments analyzed are Therapeutics, and Diagnostics. The sub product segments analyzed include Cancer, and Others.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and rest of world.
Annual forecasts are provided for each region and product segment for the period of 2000 through 2010.
The report profiles 84 companies including many key and niche players worldwide.
Contents Include:
I. Introduction, Methodology & Product Definitions
II. Executive Summery
1. Industry Overview
2. Industry Analysis
3. Product Overview
4. Diagnostic Applications of Monoclonal Antibodies
5. Monoclonal Antibody-Based Therapeutics for Cancer
6. Other Therapeutic Monoclonal Antibodies
7. Regulation Impacting The Industry
8. Contract Manufacturing
9. Research and Development Activities
10. Product Launches
11. Recent Industry Activity
12. Focus on Select Global Players
13. Global Market Perspective
III. Market
1. The Untied States
2. Canada
3. Japan
4. Europe
5. Asia-Pacific
6. Rest of World
IV. Competition
Some Companies Mentioned inside this report include: Abgenix, Inc, Altarex Corporation, American Diagnostic Corporation, American Diagnostica, Inc, American Qualex, Amgen, Inc, Antibodies, Inc, Beckman Coulter, Inc, Becton, Dickinson & Company, BD Biosciences, Bellco Glass, Inc, Berna Biotech AG, Binding Site Ltd, The Bioclone Australia Pty, Ltd, Biogen Idec, Inc, BioGenex Laboratories, Inc, Bioinvent International AB, BioMerieux SA, Biomerieux, Inc, Biomira, Inc, Biomira USA, Inc, Biosource International, Inc, Biotest AG, Calbiochem, Cambrex Corporation, Cambridge Antibody Technology, Canag Diagnostics AB, Capricorn Products, Inc, Celgene Corporation, Celltech Group Plc, Centocor, Inc, Chemicon International, Inc, Cytogen Corporation, DakoCytomation A/S, Dakocytomation California, Inc, Dakocytomation Diagnosticos SA, Dendreon Corporation, Diagnostic Systems Laboratories, Inc, DiaSorin SPA, Diasorin, Inc, DRG International, Inc, DRG Instruments GmbH, DRG Medtek SP Z O O, Elan Corporation Plc, Eli Lilly and Company, EMD Biosciences, Inc, Enzo Diagnostics, Inc, Exocell, Inc, Genentech, Inc, Genzyme Corporation, Genzyme Diagnostics, Genzyme Virotech GmbH, GlaxoSmithKline PLC, Goodwin Biotechnology, Inc, Guildhay Ltd, Human Genome Sciences, Inc, ICOS Corporation, IGEN International, Inc, ImmunoDiagnostics, Inc, Immunomedics, Inc, Immunovision, Inc, Intersciences, Inc.
